Covid-19: Budesonide shortens recovery time in patients not admitted to hospital, study finds

Study provides new insights into resistance to immune checkpoint inhibitors
12 April 2021
COVID-19 pandemic may have increased mental health issues within families
12 April 2021

Covid-19: Budesonide shortens recovery time in patients not admitted to hospital, study finds

Inhaled budesonide, a common corticosteroid used to treat asthma and chronic obstructive pulmonary disease, can shorten the time it takes for people not admitted to hospital to recover from covid-19…

Comments are closed.